Jan 10, 2024 / 03:30PM GMT
Anupam Rama JPMorgan Chase&Co.-Analyst
All right, let's go ahead and get started. Welcome everyone to the 42nd Annual JPMorgan Healthcare Conference. My name's Anupam Rama; I'm one of the senior biotech analysts here at JPMorgan. I'm joined by my squad, Priyanka Grover, LaRhea Hall, and Malcolm Kuno.
Our next presenting -- our first presenting company of the day is Kodiak. And presenting on behalf of the company, we have CEO, Victor Perlroth. Victor?
Victor Perlroth Kodiak Sciences Inc-Chairman&CEO
Thank you, Anupam. It's my pleasure once again to be presenting here at your conference. I'd like to start with a quick recap of what 2023 represented to Kodiak.
So on the one hand, as to the negative, it was an exceptionally hard year. Our twin tarcocimab DME registrational studies, GLEAM and GLIMMER, did not meet their primary endpoint due to an unexpected increase in late cataract events. These two studies were the two confirmatory studies we needed in one primary indication to file our
Kodiak Sciences Inc at JPMorgan Healthcare Conference Transcript
Feb 07, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers